𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia

✍ Scribed by Masaaki Fukutoku; Shiro Shimizu; Yoshimi Ogawa; Shouichi Takeshita; Yasuhumi Masaki; Toshihide Arai; Yuko Hirose; Susumu Sugai; Susumu Konda; Tomoo Takiguchi

Book ID
114713605
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
419 KB
Volume
86
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sweet's syndrome associated with sargram
Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment
✍ Geetika Kumar; Jack M. Bernstein; Jill S. Waibel; Michael A. Baumann πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

## Abstract Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation. This complication has not previously been reported during treatment with sargramostim

Combination Therapy With Recombinant Hum
Combination Therapy With Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin in Aplastic Anemia
✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 430 KB πŸ‘ 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients